- Home
- UPXI vs SNES Comparison
UPXI vs SNES Comparison
Compare UPXI & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPXI
- SNES
- Stock Information
- Founded
- UPXI 2018
- SNES 2004
- Country
- UPXI United States
- SNES United States
- Employees
- UPXI N/A
- SNES N/A
- Industry
- UPXI Medicinal Chemicals and Botanical Products
- SNES Agricultural Chemicals
- Sector
- UPXI Health Care
- SNES Industrials
- Exchange
- UPXI Nasdaq
- SNES Nasdaq
- Market Cap
- UPXI 3.6M
- SNES 2.9M
- IPO Year
- UPXI 2021
- SNES 2016
- Fundamental
- Price
- UPXI $15.51
- SNES $2.27
- Analyst Decision
- UPXI
- SNES Strong Buy
- Analyst Count
- UPXI 0
- SNES 1
- Target Price
- UPXI N/A
- SNES $10.00
- AVG Volume (30 Days)
- UPXI 6.5M
- SNES 44.4K
- Earning Date
- UPXI 05-07-2025
- SNES 05-08-2025
- Dividend Yield
- UPXI N/A
- SNES N/A
- EPS Growth
- UPXI N/A
- SNES N/A
- EPS
- UPXI N/A
- SNES N/A
- Revenue
- UPXI $18,625,089.00
- SNES $1,857,000.00
- Revenue This Year
- UPXI $299.03
- SNES $130.53
- Revenue Next Year
- UPXI N/A
- SNES $80.00
- P/E Ratio
- UPXI N/A
- SNES N/A
- Revenue Growth
- UPXI 4.75
- SNES 55.66
- 52 Week Low
- UPXI $1.90
- SNES $1.30
- 52 Week High
- UPXI $22.53
- SNES $9.80
- Technical
- Relative Strength Index (RSI)
- UPXI 88.68
- SNES 58.80
- Support Level
- UPXI $9.81
- SNES $1.77
- Resistance Level
- UPXI $22.00
- SNES $2.16
- Average True Range (ATR)
- UPXI 2.41
- SNES 0.22
- MACD
- UPXI 1.41
- SNES 0.10
- Stochastic Oscillator
- UPXI 65.96
- SNES 100.00
About UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products. It reaches consumers through its direct-to-consumer network, wholesale partnerships, and prominent third-party platforms like Amazon.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.